Search
for
Sort by
Research 511–540 of 1000+
- Alopecias
- 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA
- Androgenic disorders
- Investigation of hub genes and immune infiltration in androgenetic alopecia using bioinformatics analysis
- Тіе Modern treatment of androgenetic alopecia
- Acquired Progressive Kinking of Hair
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Tissue-Selective Regulation of Androgen-Responsive Genes
- Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
- Evidence-based approach to cutaneous hyperandrogenism in women
- Approach to androgen excess in women: Clinical and biochemical insights
- A recently characterized, underdiagnosed cause of female androgenetic alopecia and polycystic ovarian syndrome: non-classical 21 hydroxylase deficiency
- Hair-growth as anti-aging
- Antifungal activity and hair growth stimulation of purple sweet potato leaf fraction (Ipomoea batatas (L.) Lamk) and its molecular mechanism through androgen receptor inhibition
- Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism
- Gender differences in skin: A review of the literature
- Hair Loss in Women
- What causes hidradenitis suppurativa ?—15 years after
- Treatment of MSCs with Wnt1a-conditioned medium activates DP cells and promotes hair follicle regrowth
- Alterations in Hair Follicle Dynamics in Women
- Acne severity and the Global Acne Grading System in polycystic ovary syndrome
- Hormonal Parameters in Androgenetic Hair Loss in the Male
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Ovary and uterus related adverse events associated with statin use: an analysis of the FDA Adverse Event Reporting System
- A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2
- Are 2D:4D finger-length ratios an indicator of androgenetic alopecia in males?
- Relationship between working hours and probability to take alopecia medicine among Korean male workers: a 4-year follow-up study
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- Rotterdam criteria–based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study
- Nails and hair